leisure time -WSS

leisure time

author：entertainment 2025-09-30 22:09:02 - browse：3558

The Johnson and Johnson booth at ESMO in Madrid. — The Johnson & Johnson booth at ESMO 2023. Andrew Joseph/STAT

MADRID — A competition has been brewing between two pharma titans — Johnson & Johnson and AstraZeneca — to gain an edge in the market for targeted lung cancer treatments. A primetime presentation here Monday amounted to the latest salvo.

At the annual meeting of the European Society for Medical Oncology, J&J unveiled three studies of its drug Rybrevant in different patient groups with non-small cell lung cancer with EGFR mutations. All were successful, with the drug, sometimes used in combination with other therapies, helping stave off progression of the disease.

In an interview, Mark Wildgust, J&J’s vice president of global medical affairs for oncology, framed the totality of the research as a case that Rybrevant could become a regularly used treatment for these patients.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Vaccine advisory panel ACIP left half staffed by HHS

WSS

DeSantis and Newsom agree to Sean Hannity debate, then disagree on the rules

How digital tools helped lower hypertension in marginalized patients

Trump lawyer welcomes Pence testifying in Jan. 6 trial, won't say if Trump will too

Trump lawyer welcomes Pence testifying in Jan. 6 trial, won't say if Trump will too

What should King Charles tell the public about his cancer?

Judges halt a Biden rule offering student debt relief for those alleging colleges misled them

hotspot

leisure time

hotspot

Trump demands the U.S. pay no more for drugs than other countries … again

Prince Harry and Meghan to work on film adaptation of 'Meet Me at the Lake' novel

Sports medicine is finally prioritizing gender equality

Why did Pfizer dish out millions for a Super Bowl ad?

Duchenne breakthrough therapy leaves behind pioneering families

Elon Musk says he may need surgery before proposed 'cage match' with Mark Zuckerberg

Medical records are filled with copy

'The Exorcist' director William Friedkin dead at 87

Medicare details structure of new drug price negotiation program

To avoid data mishandling cases, universities eye AI and other tools

entertainment

Elon Musk says he may need surgery before proposed 'cage match' with Mark Zuckerberg

Mississippi candidates for statewide offices square off in party primaries

DeSantis and Newsom agree to Sean Hannity debate, then disagree on the rules

To avoid data mishandling cases, universities eye AI and other tools

What should King Charles tell the public about his cancer?

To avoid data mishandling cases, universities eye AI and other tools

hotspot

explore

focus

hotspot